Resources Investment Advisors, Llc. Regeneron Pharmaceuticals, Inc. Transaction History

Resources Investment Advisors, Llc.

$8.43 Billion
Q3 2024

A detailed history of Resources Investment Advisors, Llc. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Resources Investment Advisors, Llc. holds 1,006 shares of REGN stock, worth $777,638. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,006

Previous 1,010 0.4%

Holding current value

$777,638

Previous $1.06 Million 0.38%

% of portfolio

0.01%

Previous 0.01%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	SELL	$1024.09 - $1201.76 $4,096 - $4,807	-4 Reduced 0.4%	1,006 $1.06 Million
Q2 2024 Aug 02, 2024	BUY	$883.2 - $1071.19 $159,859 - $193,885	181 Added 21.83%	1,010 $1.06 Million
Q1 2024 May 10, 2024	BUY	$902.69 - $993.35 $319,552 - $351,645	354 Added 74.53%	829 $797,000
Q4 2023 Feb 13, 2024	BUY	$775.18 - $881.7 $37,983 - $43,203	49 Added 11.5%	475 $417,000
Q3 2023 Nov 14, 2023	SELL	$692.45 - $844.37 $107,329 - $130,877	-155 Reduced 26.68%	426 $350,000
Q2 2023 Aug 07, 2023	SELL	$700.03 - $830.35 $25,901 - $30,722	-37 Reduced 5.99%	581 $417,000
Q1 2023 May 10, 2023	SELL	$680.49 - $826.97 $48,314 - $58,714	-71 Reduced 10.3%	618 $507,000
Q4 2022 Feb 02, 2023	SELL	$705.89 - $766.39 $208,237 - $226,085	-295 Reduced 29.98%	689 $497,000
Q3 2022 Nov 08, 2022	BUY	$573.97 - $724.32 $357,583 - $451,251	623 Added 172.58%	984 $678,000
Q2 2022 Aug 08, 2022	SELL	$548.35 - $738.84 $6,031 - $8,127	-11 Reduced 2.96%	361 $213,000
Q1 2022 May 05, 2022	SELL	$595.12 - $698.43 $1,190 - $1,396	-2 Reduced 0.53%	372 $260,000
Q4 2021 Feb 23, 2022	SELL	$543.48 - $670.97 $1,630 - $2,012	-3 Reduced 0.8%	374 $236,000
Q3 2021 Nov 05, 2021	SELL	$574.03 - $680.96 $17,220 - $20,428	-30 Reduced 7.37%	377 $228,000
Q2 2021 Aug 09, 2021	BUY	$472.8 - $558.54 $192,429 - $227,325	407 New	407 $227,000
Q1 2021 May 10, 2021	SELL	$446.73 - $548.2 $265,357 - $325,630	-594 Closed	0 $0
Q4 2020 Feb 08, 2021	BUY	$478.3 - $607.98 $65,527 - $83,293	137 Added 29.98%	594 $286,000
Q3 2020 Oct 09, 2020	BUY	$544.75 - $658.21 $248,950 - $300,801	457 New	457 $255,000
Q3 2019 Nov 08, 2019	SELL	$273.46 - $318.39 $80,397 - $93,606	-294 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$299.6 - $414.82 $61,418 - $85,038	205 Added 230.34%	294 $0
Q1 2019 May 10, 2019	SELL	$372.08 - $439.57 $3,720 - $4,395	-10 Reduced 10.1%	89 $0
Q4 2018 Feb 12, 2019	BUY	$335.82 - $403.04 $33,246 - $39,900	99 New	99 $37,000
Q3 2018 Nov 07, 2018	SELL	$351.14 - $408.51 $70,579 - $82,110	-201 Closed	0 $0
Q2 2018 Aug 15, 2018	SELL	$284.6 - $344.99 $1,138 - $1,379	-4 Reduced 1.95%	201 $69,000
Q1 2018 May 14, 2018	BUY	$315.82 - $393.78 $28,423 - $35,440	90 Added 78.26%	205 $71,000
Q4 2017 Jan 31, 2018	SELL	$358.63 - $469.95 $3,586 - $4,699	-10 Reduced 8.0%	115 $43,000
Q3 2017 Nov 13, 2017	SELL	$431.38 - $504.0 $2,588 - $3,024	-6 Reduced 4.58%	125 $56,000
Q2 2017 Aug 14, 2017	BUY	N/A	131	131 $64,000

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.8M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $82.9B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Resources Investment Advisors, Llc., based on Form 13F filings with the SEC.

News

Stay updated on Resources Investment Advisors, Llc. with notifications on news.

Account

Resources Investment Advisors, Llc. Regeneron Pharmaceuticals, Inc. Transaction History